Ms. Neha Manpuria

Yeah, thanks for taking my question. My first question is on the India business. I think, you mentioned 200-400 basis points higher growth in India versus the market. I can see that obviously there has been an improvement in growth in the last two quarters for Zy dus. Could you talk a little bit about what gives you the confidence on maintaining this outperformance incrementally?

Understood. And, second, you mentioned about the Saro investment . Could you provide some color on what you think the investment for Saro would be in Fiscal 27 to build out the commercial? And another unrelated question, given the investments that we've made in different areas, you know, CDMO, MedTech, Specialty business now with Assertio, could you provide us some milestones that we need to watch to give us…

Sorry, Sir, I missed that number. What did you say? Apologies, I missed that number.